Annovis Bio (ANVS) investor relations material

Executive summary

• Special Meeting scheduled for October 14, 2026, to be held virtually for all shareholders of record as of September 4, 2026.

• Three main proposals: increase in authorized shares, ratification of equity plan amendment, and potential adjournment to solicit more proxies.

• Board of Directors unanimously recommends voting in favor of all proposals.

Voting matters and shareholder proposals

• Proposal 1: Amend Certificate of Incorporation to increase authorized Common Stock from 70M to 140M and Preferred Stock from 2M to 10M.

• Proposal 2: Ratify amendment to the 2019 Equity Incentive Plan, correcting a prior typographical error and increasing the share reserve to 5.5M shares.

• Proposal 3: Approve adjournment of the meeting if more time is needed to solicit proxies.

• Board recommends a vote "FOR" all proposals.

• Shareholders must provide explicit voting instructions for Proposals 1 and 2; otherwise, shares will not be voted on these matters.

Board of directors and corporate governance

• Directors and executive officers collectively own approximately 15.92% of outstanding common stock.

• No special benefits to directors or officers from the proposals, except potential participation in the Option Plan.

• Procedures for shareholder proposals and director nominations for the 2027 Annual Meeting are outlined, with specific deadlines.